Cargando…
MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
OBJECTIVE: We aimed to assess MET intratumoral heterogeneity and its potential impact on biomarker-based patient selection as well as potential surrogate biomarkers of MET activation. METHODS: Our study included 120 patients with non-squamous Non-small-cell Lung Cancer (nsNSCLC), of which 47 were in...
Autores principales: | Casadevall, David, Gimeno, Javier, Clavé, Sergi, Taus, Álvaro, Pijuan, Lara, Arumí, Miriam, Lorenzo, Marta, Menéndez, Silvia, Cañadas, Israel, Albanell, Joan, Serrano, Sergio, Espinet, Blanca, Salido, Marta, Arriola, Edurne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599265/ https://www.ncbi.nlm.nih.gov/pubmed/26041880 |
Ejemplares similares
-
ROS1 copy number alterations are frequent in non-small cell lung cancer
por: Clavé, Sergi, et al.
Publicado: (2016) -
MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines
por: Arriola, E, et al.
Publicado: (2011) -
High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients
por: Cañadas, Israel, et al.
Publicado: (2014) -
FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors
por: Carracedo, Alma, et al.
Publicado: (2009) -
Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer
por: Clavé, Sergi, et al.
Publicado: (2023)